PubMed COVID-19 Clinical Care

Despite the continued spread of SARS-CoV-2 and emergence of variants of concern (VOC) that are capable of escaping preexisting immunity, therapeutic options are underutilized. In addition to preventing severe disease in high-risk patients, antivirals

The new coronavirus currently named SARS-CoV-2 was announced by the World Health Organization as the virus causing the COVID-19 pandemic. The pathogenesis of SARS-CoV-2 initiates upon contact of a structural spike protein with the angiotensin II

[This retracts the article DOI: 10.2147/PRBM.S371787.].

2019-nCoV Omicron variant has become predominant in the world. New subvariants with further mutations in their spike proteins are continuously emerging. Compared with the wild type and other variants of concern, Omicron variant exhibits altered

Since the emergence of the Omicron variant of SARS-CoV-2, though considered less virulent, hospitalization and death rates among immunocompromised patients remain high, especially for poor responders to vaccination. We conducted a retrospective

BACKGROUND: Interdisciplinary interventions for school-based mental health promotion (SBMHP) for adolescents (10-19 years old) provide a unique opportunity to address the urgent mental health needs across this population. EspaiJove.net, a SBMHP

The purpose of this study is to determine the perception of coronavirus in children between the ages of 7-18 through the interpretation of metaphors. This qualitative study was conducted with a total of 34 children between the ages of 7-18 years The

CONCLUSIONS: Psychological and sleep disturbances are common among medical staff at work during the COVID-19 pandemic. More psychological intervention should be administrated for FMS, especially for nurses.

CONCLUSIONS: Inactivated SARS-CoV-2 vaccines could induce robust humoral immune response that gradually declined within several months after the second dose. Therefore, it helps to determine whether children receive a booster dose and elicit a long

CONCLUSIONS: The results indicated that hypertension is a common comorbid disease in hospitalized patients with COVID-19, which significantly increases mortality risk, the severity of the disease, and the probability of ICU admission.